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Abstract
In eukaryotic cells, replication of genomic DNA initiates from multiple replication origins
distributed on multiple chromosomes. To ensure that each origin is activated precisely only once
during each S phase, a system has evolved which features periodic assembly and disassembly of
essential pre-replication complexes (pre-RCs) at replication origins. The pre-RC assembly reaction
involves the loading of a presumptive replicative helicase, the MCM2-7 complexes, onto chromatin
by the origin recognition complex (ORC) and two essential factors, CDC6 and Cdt1. The
eukaryotic cell cycle is driven by the periodic activation and inactivation of cyclin-dependent kinases
(Cdks) and assembly of pre-RCs can only occur during the low Cdk activity period from late mitosis
through G1 phase, with inappropriate re-assembly suppressed during S, G2, and M phases. It was
originally suggested that inhibition of Cdt1 function after S phase in vertebrate cells is due to
geminin binding and that Cdt1 hyperfunction resulting from Cdt1-geminin imbalance induces re-
replication. However, recent progress has revealed that Cdt1 activity is more strictly regulated by
two other mechanisms in addition to geminin: (1) functional and SCFSkp2-mediated proteolytic
regulation through phosphorylation by Cdks; and (2) replication-coupled proteolysis mediated by
the Cullin4-DDB1Cdt2 ubiquitin ligase and PCNA, an eukaryotic sliding clamp stimulating replicative
DNA polymerases. The tight regulation implies that Cdt1 control is especially critical for the
regulation of DNA replication in mammalian cells. Indeed, Cdt1 overexpression evokes
chromosomal damage even without re-replication. Furthermore, deregulated Cdt1 induces
chromosomal instability in normal human cells. Since Cdt1 is overexpressed in cancer cells, this
could be a new molecular mechanism leading to carcinogenesis. In this review, recent insights into
Cdt1 function and regulation in mammalian cells are discussed.
Background
In eukaryotic cells, genomic DNA is fragmented into mul-
tiple chromosomes and DNA replication initiates from
multiple replication origins distributed on these. There-
fore, the amount of DNA replicated from each origin is
relatively short, allowing genome size to expand during
the evolution of eukaryotic cells. However, effective oper-
ation of the "multiple replication origin" system gives rise
to an important problem: i.e. multiple replication origins
should each be activated precisely only once during each
S phase. It is now clear that the "once and only once rep-
lication per single cell cycle" is achieved by the periodic
assembly and disassembly of essential pre-replication
complexes (pre-RCs) at replication origins [1-3]. The pre-
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RC assembly reaction, known as "licensing", involves the
loading of a presumptive replicative helicase, the MCM2-
7 complex, onto chromatin by the origin recognition
complex (ORC) and two essential factors, CDC6 and Cdt1
[4,5]. The eukaryotic cell cycle is driven by the periodic
activation and inactivation of cyclin-dependent kinases
(Cdks), pre-RC assembly only occurring in a window of
time during the low Cdk period from late mitosis through
G1 phase. Thus inappropriate re-assembly is suppressed
during S, G2, and M phases.
It was originally suggested that geminin plays a crucial
role in suppression of Cdt1 function after S phase in ver-
tebrate cells [6-8] and that Cdt1 hyperfunction resulting
from Cdt1-geminin imbalance induces re-replication [9-
15]. However, recent progress has revealed that Cdt1
activity is very strictly controlled not only by geminin but
also by two other mechanisms after S phase [16-21]. In
addition, it has been shown that Cdt1 overexpression
evokes chromosomal damage even without inducing re-
replication [22]. In this review, recent insights into Cdt1
function and regulation in mammalian cells are summa-
rized and questions that remain to be solved in the future
are also discussed.
Cell cycle regulation of pre-RC assembly in 
mammalian somatic cells
In this section, a current model for cell cycle regulation of
pre-RC assembly in mammalian cells is summarized (Fig-
ure 1). For more detailed and generalized discussion of
the licensing reaction and its regulation, see previous
review articles [1-3].
Two critical inhibitory factors for the pre-RC assembly are
cyclin/Cdks (Cdk1 and Cdk2) and geminin. During late
mitosis through the G1 phase, a cell cycle regulatory E3
ubiquitin ligase called the anaphase promoting complex/
cyclosome (APC/C) [23,24] is activated and restrains cyc-
lins and geminin by targeting them for proteolysis
through polyubiquitination. Thus, pre-RC assembly only
occurs during this period (Figure 1A). In mammalian
cells, pre-RCs are constructed based on ORC binding to
chromatin and the nuclear matrix [25]. Differing from
budding yeast ORC, the interaction of mammalian ORC
with chromosomal DNA is not simply determined by the
primary DNA sequence [1,2,26,27], rather being influ-
enced by high-order chromatin/nuclear structures associ-
ated with transcription [28]. It has also been suggested
that chromatin regions affixed to the nuclear matrix may
more easily access functional ORC because of it associa-
tion with the matrix [25]. CDC6 and Cdt1 proteins are
recruited probably by physical interaction with ORC, and
the resultant machinery functions as a loader for the
MCM2-7 complex, a presumptive replicative helicase
[29,30]. In mammalian cells, multiple MCM complexes
appear to be loaded beyond each ORC site [25], which
may function as a failsafe mechanism to ensure complete
genome duplication [31]. In addition, such a broad distri-
bution of MCM complexes could explain the initiation
zones observed in mammalian cells. Finally, it is worthy
of note that transcription of ORC1, CDC6, Cdt1 and all
MCM subunits is driven by the E2F transcription factor.
At the onset of S phase, Cdk activity is regained following
APC/C inactivation, and then pre-RCs initiate replication,
accompanied by further assembly of multiple other pro-
teins or protein complexes (Figure 1B) [2]. Firing of pre-
RCs is dependent on two kinds of kinases, Cdks and
CDC7. Prior to the DNA unwinding step, a series of pro-
teins and protein complexes such as CDC45 and the GINS
complex are further loaded to activate MCM helicase [30].
The loading is dependent on both Cdk and CDC7 kinases
and once the DNA is unwound, many components of the
DNA synthetic machinery are assembled, starting DNA
replication [2].
To prevent re-replication, the re-establishment of pre-RC,
in other words re-binding of MCM, needs to be sup-
pressed during the S, G2 and M phases of the cell cycle
(Figure 1B). Cdks play a central role also in this context [1-
3]. In mammalian cells, Cdk1 inactivation in G2 phase
results in re-binding of MCM proteins to chromatin and
subsequent re-replication [32,33]. Similarly, ablation of
cyclin A, but not cyclin B, leads to extensive re-replication
in Drosophila  tissue culture cells [34]. Cdks prevent re-
establishment of pre-RC through multiple redundant
mechanisms [1-3]. One is by phosphorylation of CDC6.
In yeast, this leads to CDC6 degradation [35] while in
mammalian cells, nuclear export is the result [36-39].
Such Cdk-dependent nuclear export of CDC6 may at least
partly contribute to prevention of re-licensing, but it
should be also noted that a significant amount of CDC6
remains bound to chromatin/nuclear matrix through S
and G2 phases [39], which may play some role in replica-
tion control [40-42]. In human cells, ORC1 is degraded
after S phase, presumably depending on phosphorylation
by cyclin A/Cdks and binding to SCFSkp2 [25,43]. It has
also been shown that the MCM complex is phosphor-
ylated by Cdks [33,44]. In budding yeast, it is necessary to
block all three effects of Cdks on ORC, CDC6, and the
MCM complex, for induction of re-replication without
inhibition of Cdk activity [45]. Also in mammalian cells,
deregulation of individual components alone, for exam-
ple overexpression of ORC1 or CDC6, fails to induce re-
replication [9,22,37,38,46], a phenomenon in line with
Cdks regulation of multiple pathways.Cell Division 2006, 1:22 http://www.celldiv.com/content/1/1/22
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Geminin: the first identified component of the 
Cdt1 inhibitory machinery
Geminin was originally identified as a novel APC/C sub-
strate in Xenopus, and found to inhibit pre-RC formation
through prevention of the loading of MCM complexes [6].
Subsequent work has shown that geminin inhibits licens-
ing by binding to and inhibiting Cdt1 (Figure 2) [7,8,47].
Since transcription of geminin is driven by the E2F tran-
scription factor [48] and geminin protein is an APC/C tar-
A model for the state of pre-replication chromatin and cell cycle regulation in human cells Figure 1
A model for the state of pre-replication chromatin and cell cycle regulation in human cells. (A) During late M to G1 phase 
when Cdk and geminin activities are suppressed by APC/C ubiquitin ligase, ORC, CDC6 and Cdt1 form the machinery on the 
nuclear matrix necessary to load MCM2-7 complexes. Multiple MCM complexes are loaded onto chromatin beyond ORC 
binding sites. (B) When cells enter S phase, CDC45 and some other proteins are recruited around MCM dependent on Cdk 
and CDC7 kinase activity, unwinding DNA. Then, DNA synthetic proteins are assembled on single-stranded DNA. Activated 
MCM plays an essential role in DNA replication, probably as a replicative DNA helicase, and is simultaneously displaced from 
chromatin through an unknown mechanism. The steps after DNA unwinding are omitted in the model shown. After S phase, 
reloading of dissociated MCM (re-licensing) is suppressed by multiple mechanisms. One is by Cdks, which phosphorylates 
ORC1 and Cdt1 so that they undergo SCFSkp2-mediated proteolysis. Phosphorylation-dependent nuclear export of chromatin-
unbound CDC6 could also contribute to inhibition of re-licensing. Cdt1 is further subjected to replication-coupled proteolytic 
regulation mediated by Cul4-DDB1Cdt2 ubiquitin ligase and PCNA. Geminin also prevents the MCM rebinding by sequestering 
Cdt1.Cell Division 2006, 1:22 http://www.celldiv.com/content/1/1/22
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get, it appears after cells enter S phase and is destroyed
during exit from mitosis to allow pre-RC formation [6-8].
At least in certain cancer-derived cell lines, depletion of
geminin by siRNA induces some re-replication [10,11].
Therefore, it is clear that geminin is a crucial factor for pre-
venting re-licensing and subsequent re-replication in
mammalian cells. However, in other cell types, geminin
depletion does not evoke overt re-replication [49]. In
Xenopus egg extracts, immunodepletion of geminin does
not induce extensive re-replication [12-15]. Also in Dro-
sophila tissue culture cells, in contrast to cyclin A deple-
tion, geminin depletion results in only partial re-
replication [34]. Therefore, both Cdks and geminin would
appear to be indispensable to securely suppress re-replica-
tion under any circumstances. Cdk-independent inhibi-
tion of pre-RC assembly by geminin would be favored in
some situations; e.g. even when Cdk activity is down-reg-
ulated by the checkpoint mechanism in cells undergoing
DNA damage, re-formation of pre-RC can be prevented by
geminin.
Recently, new functions of geminin, independent of Cdt1
binding and related to transcriptional regulation, have
been successively uncovered [50-52]. Considering that
geminin homologues are not found in yeasts, it may had
evolved in contexts other than regulation of DNA replica-
tion and thereafter have become adapted for roles in Cdt1
regulation.
Cdt1 phosphorylation by Cdks: a second 
component of the inhibitory machinery
Although Cdt1 function is suppressed by geminin after S
phase, Cdt1 might also be regulated by Cdks. Indeed, it
was found that Cdt1 is phosphorylated by cyclin A-
dependent kinases (cyclin A/Cdk1 and cyclin A/Cdk2)
dependent on the RXL-type cyclin-binding motif (Cy
motif) [16,17]. Cdk phosphorylation results in Cdt1
binding to the F-box protein Skp2, a component of the
SCF (Skp1-Cullin1-F-box protein) ubiquitin ligase com-
plex, and its subsequent degradation [16,17,53,54]. Thus,
Cdks regulate Cdt1 via phosphorylation-dependent prote-
olysis (Figure 2). However, a Cdt1 Cy mutant, which is
refractory to Cdk phosphorylation and SCFSkp2 recogni-
tion, showed only partial resistance to degradation during
S phase in Rat-1 cells [16]. Also in HeLa cells, it has been
observed that Cdt1 mutants deficient in Cdk phosphor-
ylation and subsequent SCFSkp2 binding are still degraded
A model for inhibition of Cdt1 function after entry into S phase Figure 2
A model for inhibition of Cdt1 function after entry into S phase. Cyclin A/Cdks phosphorylate Cdt1 on threonine 29 depending 
on cyclin A binding to RXL-type cyclin-binding motif (Cy moif) then SCFSkp2 ubiquitin ligase recognizes phosphorylated Cdt1 
and polyubiquitinated Cdt1 is degraded by proteasomes. In addition, Cdk phosphorylation inhibits Cdt1 DNA binding activity. 
During DNA replication, Cdt1 binds to PCNA on chromatin and Cul4-DDB1Cdt2 ubiquitin ligase recognizes interfaces gener-
ated by such Cdt1-PCNA interaction. This mechanism also appears to operate during repair synthesis of damaged DNA 
although the biological significance remains unclear. After S phase, geminin protein also accumulates, sequestering Cdt1 by 
direct binding.Cell Division 2006, 1:22 http://www.celldiv.com/content/1/1/22
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with comparable efficiency to the wild type [54]. These
findings clearly show that there is a separate mecha-
nism(s) that targets Cdt1 for proteolysis during S phase
(see below). Cdk phosphorylation also down-regulates
Cdt1 via a mechanism distinct from the proteolysis,
impairing its in vitro DNA binding activity [16]. In cells
arrested around G2/M phase, levels of Cdt1 protein are
not lowered but it remains detached from chromatin.
When Cdk1 is inactivated in such cells, Cdt1 is dephos-
phorylated and rebinds to chromatin [16]. Cdk phospho-
rylation-mediated inhibition of Cdt1 DNA binding
activity provides one possible explanation for such phe-
nomenon.
Unscheduled Cdt1 hyperfunction induces re-replication
[9] and chromosomal damage without re-replication
[22]. In Rat-1 cells, the Cdt1 Cy mutant induces stronger
chromosomal damage than the wild type [22]. Also in
HeLa cells, Cdt1 mutants deficient in Cdk phosphoryla-
tion exhibit more extensive re-replication, despite their
efficient degradation [21,54]. These findings support an
importance for Cdt1 regulation by Cdks, especially in a
proteolysis-independent manner such as inhibition of
Cdt1 DNA binding activity. Cdk-mediated regulation of
Cdt1 has subsequently also been noted in Drosophila [55].
In mammalian cells, Cdk1 inactivation in G2 phase pro-
motes inappropriate re-licensing [33]. The question there-
fore arises why geminin cannot inhibit re-licensing under
this circumstance. Are interactions between Cdt1 and
geminin directly affected by Cdks? This may not be the
case [16]. Geminin is a substrate of APC/CCdh1 ubiquitin
ligase and Cdks restrains this ligase by phosphorylating
Cdh1 subunit [23,24]. Therefore, Cdk inhibition could
simultaneously induce geminin inactivation by APC/C. In
this regard, it is notable that APC/C-mediated inhibition
of geminin does not necessarily require degradation by a
proteasome and ubiquitination itself may be sufficient
[56]. A more simple explanation could be that only gem-
inin binding is insufficient to inhibit Cdt1 when it escapes
from degradation.
One more piece of Cdt1 inhibitory machinery: 
replication-coupled degradation mediated by 
the Cullin4 (Cul4)-based ubiquitin ligase and 
proliferating cell nuclear antigen (PCNA)
Recently, Cul4-based ubiquitin ligase- and PCNA-medi-
ated proteolysis has emerged as a third mechanism regu-
lating Cdt1 during the S phase (Figure 2). Four groups
have reached the same conclusion, as successively
reported in the beginning of this year [18-21].
Cul4 is a member of the Cullin ubiquitin ligase family
[57,58], together with the SCF constructed based on Cul1
[23,24,59]. Involvement of Cul4 in regulation of Cdt1
function was first suggested in C. elegans, in which abla-
tion of Cul4 by RNAi induces re-replication which is in
turn suppressed by removal of one genome copy of Cdt1
[60]. The level of C. elegans Cdt1 protein is decreased as
cells enter S phase, and this decrease disappears with Cul4
depletion. Thus, the Cul4 ubiquitin ligase appears to reg-
ulate Cdt1 stability during S phase, albeit by a mechanism
which remains to be elucidated. Subsequently, it was
found that in human cells, Cdt1 is rapidly targeted for
proteasome-mediated degradation after DNA damage by
UV irradiation and that this proteolysis involves ubiquiti-
nation of Cdt1 by Cul4-DDB1 ligase [61,62]. It has been
shown that Cul4-DDB1 ubiquitin ligase immunopurified
from cells can catalyze Cdt1 polyubiquitination in vitro
and that DDB1 can directly bind to Cdt1 [61,62]. How-
ever, it remains unclear how Cdt1 is specifically recog-
nized by Cul4-DDB1 ligase only when chromatin is
damaged. Furthermore, the biological significance of
Cdt1 degradation after chromatin damage has also been
somewhat vague. Once MCM complexes are loaded onto
chromatin, ORC, CDC6, and Cdt1 appear to be no longer
required for the initiation reaction. Therefore, Cdt1
removal after DNA damage might not be expected to con-
tribute to blocking S phase entry.
Recent progress has resolved this question. Cdt1 has a
PCNA-interaction protein motif (PIP motif; QxxI/L/
VxxFF) [63,64] in the N-terminus, which is conserved
from  C. elegans to mammalian cells [18-21]. As men-
tioned above, mutations that abrogate Skp2 binding can-
not completely stabilize human Cdt1 during S phase.
Interestingly, it was shown that additional mutations in
the PIP motif does block S phase degradation [19,21].
Silencing of Cul4 or DDB1 by siRNA also stabilizes
mutant Cdt1 deficient in Skp2 binding [19,21]. Thus, pro-
teolytic regulation of human Cdt1 during S phase is car-
ried out by two redundant pathways, involving SCFSkp2-
and Cul4-DDB1-mediated ubiquitination. Indeed, co-
inhibition of both pathways by siRNA can stabilize wild
type human Cdt1 in S phase [21]. The finding that the PIP
motif is required for Cul4-DDB1-mediated proteolysis
indicates a possible involvement of PCNA. In fact, Cdt1
binds to PCNA via the PIP motif and silencing of PCNA
by siRNA as well as the PIP mutation can stabilize the
mutant Cdt1 deficient in Skp2 binding during the S phase
[19,21]. Essentially the same results have been also
obtained with an in vitro DNA replication system using
Xenopus egg extracts although the Cdk-SCFSkp2 system does
not seem to operate in this case [18]. Considering that
ablation of Cul4 induces overt re-replication in C. elegans,
Cul4-mediated degradation of Cdt1 may be of prime
importance in this organism although it remains possible
that Cul4 is also involved in other systems associated with
replication control (see below). Interestingly, Cdt1 prote-
olytic regulation involving PCNA and Cul4 is alsoCell Division 2006, 1:22 http://www.celldiv.com/content/1/1/22
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observed in fission yeast [20]. We can conclude that a
strict regulation system has evolved to control Cdt1 (Fig-
ure 2).
PCNA, a eukaryotic sliding clamp, is present in the nuclei
throughout the cell cycle and loaded onto the primer ends
synthesized on unwound DNA during S phase. Then, it
recruits replicative DNA polymerases and stimulates their
activity [63,64]. PCNA also recruits many other PCNA-
binding proteins which regulate replication-associated
processes [63,64]. Although detailed mechanisms remain
to be clarified, a line of evidence indicates that only chro-
matin-loaded PCNA can trigger Cdt1 ubiquitination by
Cul4-DDB1, ensuring a timely, replication-coupled degra-
dation of Cdt1 to prevent re-licensing [18,19,21]. Very
importantly, a prokaryote, E. coli also employs a similar
strategy to prevent re-initiation of DNA replication, where
an initiation factor, DnaA is inactivated via a prokaryotic
sliding clamp, the β clamp [65,66]. Thus, DNA replica-
tion-coupled, sliding clamp-mediated inactivation of ini-
tiation factors appears to be a universal system to prevent
re-replication and maintain genome stability. PCNA is
also loaded onto chromatin during repair synthesis of
damaged DNA that operates outside of S phase. As
expected from this, DNA damage-induced, Cul4-DDB1
ligase-mediated Cdt1 degradation also depends on
PCNA-Cdt1 interaction [19-21]. The DNA damage-
induced Cdt1 degradation might be a "by-product" of
machinery for replication-coupled degradation. An
intriguing question is whether DNA damage-induced
Cdt1 degradation indeed contributes to genome stability.
Several other important points also need to be resolved.
Cul4-DDB1 ubiquitin ligase may recognize an interface
generated by Cdt1-PCNA interaction, but it is unclear how
this ligase only recognizes Cdt1-PCNA complexes formed
on chromatin. One simple explanation is that functional
Cul4-DDB1 could be always tethered to chromatin. Since
there are many PCNA-binding proteins, it is of interest
why Cdt1 (and possibly some other targets) is ubiquiti-
nated by Cul4 and brought to proteolysis while others are
not. In this context, it should be noted that the Xenopus
p27Xic1 Cdk inhibitor is also targeted to degradation in a
PCNA-dependent manner, although involvement of Cul4
has not been examined [67]. Presumably, Cul4-DDB1
ligase recognizes specific interfaces generated between
PCNA and target proteins that should be ubiquitinated. It
is conceivable that in addition to the PIP motif, some spe-
cific amino acid residues are also required for recognition
by Cul4-DDB1 ligase, identification of which is a worthy
research challenge. By analogy with SCF ubiquitin ligase,
Cul4 is equivalent to Cul1 and DDB1 may be equivalent
to Skp1 (Figure 2) [57-59]. In the SCF ubiquitin ligase,
each of many F-box proteins that bind to Skp1 acts as a
specific substrate-recognition subunit and in the case of
Cdt1, it is Skp2 [16,17]. So, what are the proteins playing
roles in Cdt1 recognition by Cul4-DDB1 ligase? During
drafting of this review, a WD40-repeat-containing pro-
tein, Cdt2 was identified as a candidate substrate receptor
for the Cdt1-PCNA interface, although direct proof is still
lacking [68,69]. It should be noted that Cdt2 was origi-
nally identified in a same screening with Cdt1 in fission
yeast but that they are structurally unrelated [70]. Finally,
ubiquitination by Cul4-based ligase has been also impli-
cated in regulation of other important chromatin pro-
teins, including DNA repair-related factors, core histones
and p53 [58,71]. Therefore, it may be necessary to con-
sider cross-integration of these different chromatin trans-
actions by Cul4 ubiquitin ligase.
Why is Cdt1 regulated so strictly by multiple 
mechanisms and what occurs when the strict 
regulation is perturbed: to be or not to be re-
replicated?
The fact that Cdt1 activity is controlled by multiple mech-
anisms in human cells suggests that its deregulation may
induce more deleterious insult than with other pre-RC
components such as ORC1 and CDC6. Indeed, it is
reported that overexpression of Cdt1 can induce overt re-
replication in cancer-derived cell lines, with activation of
ATM/ATR checkpoint pathways [9]. This contrasts to the
fact that overexpression of ORC1 or CDC6 has no or only
marginal effects on cell cycle progression [9,22,37,38,46].
As discussed above, Cdks utilize multiple mechanisms to
prevent re-replication (Figure 1B). For example, it has
been reported that ORC1 protein is degraded after entry
into S phase in several cancer-derived cell lines [25,43].
This is also the case in all human cell lines we have tested
(including non-transformed cell lines), without exception
(own unpublished data). Naturally, Cdt1 cannot com-
pensate for ORC1 function. So, why can overexpression of
Cdt1 alone induce overt re-replication? The fact that Cdt1-
induced re-replication has been observed in cancer-
derived cell lines could provide an answer. Cancer cells
constitutively overexpress replication initiation factors
such as ORC1, CDC6, Cdt1, and MCM [22], so that ORC1
degradation in S phase may be insufficient to fully sup-
press its function. Consistent with this idea, we have
observed that cell growth is severely inhibited in normal
human fibroblasts when ORC1 protein level is reduced by
~80% with shRNA expression while it is not in cancer-
derived HeLa cells (own unpublished data). Cdt1-
induced re-replication is also observed in the Xenopus egg
extract system [12-15], a system that may be representa-
tive of rapid early embryonic cell cycling in vertebrates.
The cause could be large amounts of maternal initiation
proteins in the eggs. It has been also suggested that ORC
function is not inhibited during S phase in this system
[72]. Under physiological conditions, strict control of
Cdt1 by multiple pathways may be particularly crucial inCell Division 2006, 1:22 http://www.celldiv.com/content/1/1/22
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situations characterized by rapid cell cycling such as in the
early embryo [73]. It has been proposed that induction of
re-replication by Cdt1 overexpression in cancer cells is
suppressed by p53 activated by ATM/ATR pathways [9].
On the other hand, re-replication upon geminin deple-
tion in cancer cells is observed regardless of the p53 status
[10,11]. The reason for this apparent difference is not
clear at present.
In non-transformed cultured cells, Cdt1 overexpression at
pathophysiological levels appears not to induce re-repli-
cation but nevertheless leads to chromosomal damage, as
revealed by activation of the ATM-Chk2 DNA damage
checkpoint pathway [22]. Furthermore, deregulation of
Cdt1 causes such damage even in quiescent cells and is
associated with chromosomal instability in normal
human cells [22]. Together, these findings demonstrate
that the strict regulation of Cdt1 is also important for the
normal somatic cell cycle. The mechanisms by which
Cdt1 overexpression negatively impacts on chromatin
remain to be clarified. One possibility is that DNA dou-
ble-strand breaks are involved, although their direct detec-
tion has so far not been reported. Another possibility is
that the presence of Cdt1 in the quiescent state or after S
phase inappropriately changes chromatin architecture,
either directly or indirectly through recruiting other pro-
tein(s), activating ATM [74]. As components of the MCM
complex-loading machinery, ORC and CDC6 proteins act
using their ATPase activity as does replication factor C, a
loader for PCNA [2]. However, it remains unclear how
Cdt1 acts during MCM loading. Alteration of the chroma-
tin structure by Cdt1 could be related to its physiological
role in MCM loading, an intriguing possibility that should
be tested in future.
There is evidence that silencing of geminin induces re-rep-
lication, suggested to be attributable to Cdt1 deregulation
[10,11]. However, it should be noted that cancer cells
have been used in most of the reported studies and gemi-
nin has roles other than in Cdt1 inhibition, for example
in transcriptional regulation [50-52]. Similarly with the
re-replication due to inhibition of Cul4-DDB1Cdt2  by
RNAi [60,68,75], it should be considered that the ligase
may act on target proteins other than Cdt1, including Cdk
inhibitors as discussed above. In mammalian cells, PIP
motif-mutated Cdt1 is still degraded in S phase and shows
reduced ability to induce re-replication compared with
the wild type [21,54]. On the other hand, in the Xenopus
egg extract system, PIP motif-mutated Cdt1 is stabilized
and induces more re-replication than the wild type [18].
This could represent a difference in cell cycle regulation
between embryonic and somatic cells.
Is Cdt1 an oncogene?
It has been reported that Cdt1 overexpression endows
murine NIH3T3 cells with the capacity to form tumors in
nude mice [76]. However, in Rat-1, another cell line com-
monly used to estimate transformation potency of classi-
cal oncogenes, no transformed phenotype was observed
with stable overexpression of Cdt1 [22]. This difference
might simply be attributable to cell type-specific
responses. However, there is abundant evidence that
deregulation of Cdt1 impacts on cells by inducing re-rep-
lication, chromosomal damage, and genomic instability
[9,22]. Thus, I prefer the explanation that deregulated
Cdt1 does not lead to acute oncogenic transformation,
but rather to chronic chromosomal damage and instabil-
ity that eventually results in transformation. In fact, Cdt1
overexpression in transgenic thymocytes by itself does not
lead to tumor formation but modulates and enhances
tumor formation induced by p53 deficiency [77].
Importantly, Cdt1 protein is actually overexpressed in
human cancer cells [78,79,22]. Cdt1  transcription is
driven by E2F transcription factor [48], which is often
deregulated in cancer cells, for example by RB pathway
disturbance. Thus, Cdt1 deregulation would be a novel
molecular mechanism leading to carcinogenesis.
Conclusion
In mammalian cells, Cdt1 is a very central player in regu-
lation of DNA replication. During the cell cycle, strict con-
trol is exerted by geminin, by Cdk phosphorylation and
subsequent SCFSkp2-mediated proteolysis, and by replica-
tion-coupled proteolysis involving Cul4-DDB1Cdt2  and
PCNA. Details of these multiple regulations have only
recently been uncovered and many questions remain,
including how Cdt2 specifically recognizes interfaces
between Cdt1 and PCNA on chromatin and how Cul4-
DDB1 ubiquitin ligase coordinates several related chro-
matin transactions. As expected from the strict regulation,
deregulation of Cdt1 is a deleterious insult, leading to re-
replication and/or chromosomal damage. The induced
chromosomal instability may eventually lead to carcino-
genesis and Cdt1 overexpression is in fact often observed
in human cancers. The mechanisms by which Cdt1 can
damage chromatin without inducing re-replication are
unclear at present and this is an interesting research chal-
lenge. Elucidation could provide valuable information
regarding the essential question of how Cdt1 functions in
MCM loading reaction.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
MF wrote the entire manuscript.Cell Division 2006, 1:22 http://www.celldiv.com/content/1/1/22
Page 8 of 9
(page number not for citation purposes)
Acknowledgements
I thank all members of my research group for helpful discussion and critical 
reading of the manuscript. This work was supported in part by Grants to 
MF from the Ministry of Education, Culture, Sports, Science and Technol-
ogy of Japan and from The Mochida Memorial Foundation for Medical and 
Pharmaceutical Research.
References
1. Fujita M: Cell cycle regulation of DNA replication initiation
proteins in mammalian cells.  Front Biosci 1999, 4:D816-D823.
2. Bell SP, Dutta A: DNA replication in eukaryotic cells.  Annu Rev
Biochem 2002, 71:333-374.
3. Diffley JFX: Regulation of early events in chromosome replica-
tion.  Curr Biol 2004, 14:R778-R786.
4. Maiorano D, Moreau J, Mechali M: XCDT1 is required for the
assembly of pre-replicative complexes in Xenopus  laevis.
Nature 2000, 404:622-625.
5. Nishitani H, Lygerou Z, Nishimoto T, Nurse P: The Cdt1 protein
is required to license DNA for replication in fission yeast.
Nature 2000, 404:625-628.
6. McGarry TJ, Kirschner MW: Geminin, an inhibitor of DNA rep-
lication, is degraded during mitosis.  Cell 1998, 93:1043-1053.
7. Wohlschlegel JA, Dwyer BT, Dhar SK, Cvetic C, Walter JC, Dutta A:
Inhibition of eukaryotic DNA replication by geminin binding
to Cdt1.  Science 2000, 290:2309-2312.
8. Tada S, Li A, Maiorano D, Mechali M, Blow JJ: Repression of origin
assembly in metaphase depends on inhibition of RLF-B/Cdt1
by geminin.  Nat Cell Biol 2001, 3:107-113.
9. Vaziri C, Saxena S, Jeon Y, Lee C, Murata K, Machida Y, Wagle N,
Hwang DS, Dutta A: A p53-dependent checkpoint pathway pre-
vents rereplication.  Mol Cell 2003, 11:997-1008.
10. Melixetian M, Ballabeni A, Masiero L, Gasparini P, Zamponi R, Bartek
J, Lukas J, Helin K: Loss of Geminin induces rereplication in the
presence of functional p53.  J Cell Biol 2004, 165:473-482.
11. Zhu W, Chen Y, Dutta A: Rereplication by depletion of geminin
is seen regardless of p53 status and activates a G2/M check-
point.  Mol Cell Biol 2004, 24:7140-7150.
12. Arias EE, Walter JC: Replication-dependent destruction of
Cdt1 limits DNA replication to a single round per cell cycle
in Xenopus egg extracts.  Genes Dev 2005, 19:114-126.
13. Maiorano D, Krasinska L, Lutzmann M, Mechali M: Recombinant
Cdt1 induces rereplication of G2 nuclei in Xenopus  egg
extracts.  Curr Biol 2005, 15:146-153.
14. Li A, Blow JJ: Cdt1 downregulation by proteolysis and geminin
inhibition prevents DNA re-replication in Xenopus.  EMBO J
2005, 24:395-404.
15. Yoshida K, Takisawa H, Kubota Y: Intrinsic nuclear import activ-
ity of geminin is essential to prevent re-initiation of DNA
replication in Xenopus eggs.  Genes Cells 2005, 10:63-73.
16. Sugimoto N, Tatsumi Y, Tsurumi T, Matsukage A, Kiyono T, Nishitani
H, Fujita M: Cdt1 phosphorylation by cyclin A-dependent
kinases negatively regulates its function without affecting
geminin binding.  J Biol Chem 2004, 279:19691-19697.
17. Liu E, Li X, Yan F, Zhao Q, Wu X: Cyclin-dependent kinases
phosphorylate human Cdt1 and induce its degradation.  J Biol
Chem 2004, 279:17283-17288.
18. Arias EE, Walter JC: PCNA functions as a molecular platform
to trigger Cdt1 destruction and prevent re-replication.  Nat
Cell Biol 2006, 8:84-90.
19. Senga T, Sivaprasad U, Zhu W, Park JH, Arias EE, Walter JC, Dutta A:
PCNA is a co-factor for Cdt1 degradation by CUL4/DDB1
mediated N-terminal ubiquitination.  J Biol Chem 2006,
281:6246-6252.
20. Hu J, Xiong Y: An evolutionarily conserved function of prolif-
erating cell nuclear antigen for Cdt1 degradation by the
Cul4-Ddb1 ubiquitin ligase in response to DNA damage.  J Biol
Chem 2006, 281:3753-3756.
21. Nishitani H, Sugimoto N, Roukos V, Nakanishi Y, Saijo M, Obuse C,
Tsurimoto T, Nakayama KI, Nakayama K, Fujita M, Lygerou Z, Nishi-
moto T: Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4,
target human Cdt1 for proteolysis.  EMBO J 2006, 25:1126-1136.
22. Tatsumi Y, Sugimoto N, Yugawa T, Narisawa-Saito M, Kiyono T,
Fujita M: Deregulation of Cdt1 induces chromosomal damage
without rereplication and leads to chromosomal instability.
J Cell Sci 2006, 119:3128-3140.
23. Vodermaier HC: APC/C and SCF: controlling each other and
the cell cycle.  Curr Biol 2004, 14:R787-R796.
24. Nakayama KI, Nakayama k: Ubiquitin ligases: cell-cycle control
and cancer.  Nat Rev Cancer 2006, 6:369-381.
25. Fujita M, Ishimi Y, Nakamura H, Kiyono T, Tsurumi T: Nuclear
organization of DNA replication initiation proteins in mam-
malian cells.  J Biol Chem 2002, 277:10354-10361.
26. Vashee S, Cvetic C, Lu W, Simancek P, Kelly TJ, Walter JC:
Sequence-independent DNA binding and replication initia-
tion by the human origin recognition complex.  Genes Dev
2003, 17:1894-1908.
27. Schaarschmidt D, Baltin J, Stehle IM, Lipps HJ, Knippers R: An episo-
mal mammalian replicon: sequence-independent binding of
the origin recognition complex.  EMBO J 2004, 23:191-201.
28. Danis E, Brodolin K, Menut S, Maiorano D, Girard-Reydet C, Méchali
M: Specification of a DNA replication by a transcription com-
plex.  Nat Cell Biol 2004, 6:721-730.
29. Ishimi Y: A DNA helicase activity is associated with an MCM4,
-6, and -7 protein complex.  J Biol Chem 1997, 272:24508-24513.
30. Moyer SE, Lewis PW, Botchan MR: Isolation of the Cdc45/Mcm2-
7/GINS(CMG) complex, a candidate for the eukaryotic DNA
replication fork helicase.  P r o c  N a t l  A c a d  S c i  U S A  2006,
103:10236-10241.
31. Woodward AM, Göhler T, Luciani MG, Oehlmann M, Ge X, Gartner
A, Jackson DA, Blow JJ: Excess Mcm2-7 license dormant origins
of replication that can be used under conditions of replica-
tive stress.  J Cell Biol 2006, 173:673-683.
32. Itzhaki JE, Gilbert CS, Porter AC: Construction by gene targeting
in human cells of a "conditional' CDC2 mutant that rerepli-
cates its DNA.  Nat Genet 1997, 15:258-265.
33. Fujita M, Yamada C, Tsurumi T, Hanaoka F, Matsuzawa K, Inagaki M:
Cell cycle- and chromatin binding state-dependent phospho-
rylation of human MCM heterohexameric complexes. A role
for cdc2 kinase.  J Biol Chem 1998, 273:17095-17101.
34. Mihaylov IS, Kondo T, Jones L, Ryzhikov S, Tanaka J, Zheng J, Higa LA,
Minamino N, Cooley L, Zhang H: Control of DNA replication and
chromosome ploidy by geminin and cyclin A.  Mol Cell Biol
2002, 22:1868-1880.
35. Drury LS, Perkins G, Diffley JFX: The Cdc4/34/53 pathway tar-
gets Cdc6p for proteolysis in budding yeast.  EMBO J 1997,
16:5966-5976.
36. Saha P, Chen J, Thome KC, Lawlis SJ, Hou ZH, Hendricks M, Parvin
JD, Dutta A: Human CDC6/Cdc18 associates with Orc1 and
cyclin-cdk and is selectively eliminated from the nucleus at
the onset of S phase.  Mol Cell Biol 1998, 18:2758-2767.
37. Jiang W, Wells NJ, Hunter T: Multistep regulation of DNA rep-
lication by Cdk phosphorylation of HsCdc6.  Proc Natl Acad Sci
USA 1999, 96:6193-6198.
38. Petersen BO, Lukas J, Sorensen CS, Bartek J, Helin K: Phosphoryla-
tion of mammalian CDC6 by cyclin A/CDK2 regulates its
subcellular localization.  EMBO J 1999, 18:396-410.
39. Fujita M, Yamada C, Goto H, Yokoyama N, Kuzushima K, Inagaki M,
Tsurumi T: Cell cycle regulation of human CDC6 protein.
Intracellular localization, interaction with the human mcm
complex, and CDC2 kinase-mediated hyperphosphoryla-
tion.  J Biol Chem 1999, 274:25927-25932.
40. Clay-Farrace L, Pelizon C, Santamaria D, Pines J, Laskey RA: Human
replication protein Cdc6 prevents mitosis through a check-
point mechanism that implicates Chk1.  EMBO J 2003,
22:704-712.
41. Oehlmann M, Score AJ, Blow JJ: The role of Cdc6 in ensuring
complete genome licensing and S phase checkpoint activa-
tion.  J Cell Biol 2004, 165:181-90.
42. Lau E, Zhu C, Abraham RT, Jiang W: The functional role of Cdc6
in S-G2/M in mammalian cells.  EMBO Rep 2006, 7:425-430.
43. Mendez J, Zou-Yang XH, Kim SY, Hidaka M, Tansey WP, Stillman B:
Human origin recognition complex large subunit is degraded
by ubiquitin-mediated proteolysis after initiation of DNA
replication.  Mol Cell 2002, 9:481-491.
44. Hendrickson M, Madine M, Dalton S, Gautier J: Phosphorylation of
MCM4 by cdc2 protein kinase inhibits the activity of the min-
ichromosome maintenance complex.  Proc Natl Acad Sci USA
1996, 93:12223-12228.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cell Division 2006, 1:22 http://www.celldiv.com/content/1/1/22
Page 9 of 9
(page number not for citation purposes)
45. Nguyen VQ, Co C, Li JJ: Cyclin-dependent kinases prevent DNA
re-replication through multiple mechanisms.  Nature 2001,
411:1068-1073.
46. Pelizon C, Madine MA, Romanowski P, Laskey RA: Unphosphor-
ylatable mutants of Cdc6 disrupt its nuclear export but still
support DNA replication once per cell cycle.  Genes Dev 2000,
14:2526-2533.
47. Lee C, Hong B, Choi JM, Kim Y, Watanabe S, Ishimi Y, Enomoto T,
Tada S, Kim Y, Cho Y: Structural basis for inhibition of the rep-
lication licensing factor Cdt1 by geminin.  Nature 2004,
430:913-917.
48. Yoshida K, Inoue I: Regulation of Geminin and Cdt1 expression
by E2F transcription factors.  Oncogene 2004, 23:3802-3812.
49. Kulartz M, Knippers R: The replicative regulator protein gemi-
nin on chromatin in the HeLa cell cycle.  J Biol Chem 2004,
279:41686-41694.
50. Del Bene F, Tessmar-Raible K, Wittbrodt J: Direct interaction of
geminin and Six3 in eye development.  Nature 2004,
427:745-749.
51. Luo L, Yang X, Takihara Y, Knoetgen H, Kessel M: The cell-cycle
regulator geminin inhibits Hox function through direct and
polycomb-mediated interactions.  Nature 2004, 427:749-753.
52. Seo S, Herr A, Lim JW, Richardson GA, Richardson H, Kroll KL:
Geminin regulates neuronal differentiation by antagonizing
Brg1 activity.  Genes Dev 2005, 19:1723-1734.
53. Li X, Zhao Q, Liao R, Sun P, Wu X: The SCF(Skp2) ubiquitin
ligase complex interacts with the human replication licens-
ing factor Cdt1 and regulates Cdt1 degradation.  J Biol Chem
2003, 278:30854-30858.
54. Takeda DY, Parvin JD, Dutta A: Degradation of Cdt1 during S
phase is Skp2-independent and is required for efficient pro-
gression of mammalian cells through S phase.  J Biol Chem
2005, 280:23416-23423.
55. Thomer M, May NR, Aggarwal BD, Kwok G, Calvi BR: Drosophila
double-parked is sufficient to induce re-replication during
development and is regulated by cyclin E/CDK2.  Development
2004, 131:4807-4818.
56. Li A, Blow JJ: Non-proteolytic inactivation of geminin requires
CDK-dependent ubiquitination.  Nat Cell Biol 2004, 6:260-267.
57. Petroski M, Deshaies R: Function and regulation of cullin-RING
ubiquitin ligases.  Nat Rev Mol Cell Biol 2005, 6:9-20.
58. Dai Q, Wang H: Cullin 4 makes its mark on chromatin.  Cell Div
2006, 1:14.
59. Cardozo T, Pagano M: The SCF ubiquitin ligase: insight into a
molecular machine.  Nat Rev Mol Cell Biol 2004, 5:739-751.
60. Zhong W, Feng H, Santiago FE, Kipreos ET: CUL-4 ubiquitin ligase
maintains genome stability by restraining DNA-replication
licensing.  Nature 2003, 423:885-889.
61. Higa LA, Mihaylov IS, Banks DP, Zheng J, Zhang H: Radiation-medi-
ated proteolysis of CDT1 by CUL4-ROC1 and CSN com-
plexes constitutes a new checkpoint.  Nat Cell Biol 2003,
5:1008-1015.
62. Hu J, McCall CM, Ohta T, Xiong Y: Targeted ubiquitination of
CDT1 by the DDB1-CUL4A-ROC1 ligase in response to
DNA damage.  Nat Cell Biol 2004, 6:1003-1009.
63. Warbrick E: The puzzle of PCNA's many partners.  Bioessays
2000, 22:997-1006.
64. Maga G, Hubscher U: Proliferating cell nuclear antigen
(PCNA): a dancer with many partners.  J Cell Sci 2003,
116:3051-3060.
65. Katayama T, Kubota T, Kurokawa K, Crooke E, Sekimizu K: The ini-
tiator function of DnaA protein is negatively regulated by
the sliding clamp of the E. coli chromosomal replicase.  Cell
1998, 94:61-71.
66. Su'etsugu M, Shimuta TR, Ishida T, Kawakami H, Katayama T: Pro-
tein associations in DnaA-ATP hydrolysis mediated by the
Hda-replicase clamp complex.  J Biol Chem 2005, 280:6528-6536.
67. Chuang LC, Yew PR: Proliferating cell nuclear antigen recruits
cyclin-dependent kinase inhibitor Xic1 to DNA and couples
its proteolysis to DNA polymerase switching.  J Biol Chem 2005,
280:35299-35309.
68. Jin J, Arias EE, Chen J, Harper JW, Walter JC: A family of diverse
Cul4-Ddb1-interacting proteins includes Cdt2, which is
required for S phase destruction of the replication factor
Cdt1.  Mol Cell 2006, 23:709-721.
69. Higa LA, Banks D, Wu M, Kobayashi R, Sun H, Zhang H: L2DTL/
CDT2 interacts with the CUL4/DDB1 complex and PCNA
and regulates CDT1 proteolysis in response to DNA dam-
age.  Cell Cycle 5:1675-80.
70. Hofmann JF, Beach D: cdt1 is an essential target of the Cdc10/
Sct1 transcription factor: requirement for DNA replication
and inhibition of mitosis.  EMBO J 1994, 13:425-434.
71. Banks D, Wu M, Higa LA, Gavrilova N, Quan J, Ye T, Kobayashi R,
Sun H, Zhang H: L2DTL/CDT2 and PCNA interact with p53
and regulate p53 polyubiquitination and protein stability
through MDM2 and CUL4A/DDB1 complexes.  Cell Cycle 2006,
5:1719-29.
72. Rowles A, Chong JP, Brown L, Howell M, Evan GI, Blow JJ: Interac-
tion between the origin recognition complex and the repli-
cation licensing system in Xenopus.  Cell 1996, 87:287-296.
73. Gonzalez MA, Tachibana KE, Adams DJ, van der Weyden L, Hem-
berger M, Coleman N, Bradley A, Laskey RA: Geminin is essential
to prevent endoreduplication and to form pluripotent cells
during mammalian development.  Genes Dev 2006,
20:1880-1884.
74. Bakkenist CJ, Kastan MB: DNA damage activates ATM through
intermolecular autophosphorylation and dimer dissociation.
Nature 2003, 421:499-506.
75. Lovejoy CA, Lock K, Yenamandra A, Cortez D: DDB1 maintains
genome integrity through regulation of Cdt1.  Mol Cell Biol
2006 in press.
76. Arentson E, Faloon P, Seo J, Moon E, Studts JM, Fremont DH, Choi
K: Oncogenic potential of the DNA replication licensing pro-
tein CDT1.  Oncogene 2002, 21:1150-1158.
77. Seo J, Chung YS, Sharma GG, Moon E, Burack WR, Pandita TK, Choi
K: Cdt1 transgenic mice develop lymphoblastic lymphoma in
the absence of p53.  Oncogene 2005, 24:8176-8186.
78. Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG,
Kougiou D, Kouloukoussa M, Nishitani H, Papavassiliou AG, Lygerou
Z, Gorgoulis VG: Overexpression of the replication licensing
regulators hCdt1 and hCdc6 characterizes a subset of non-
small-cell lung carcinomas: synergistic effect with mutant
p53 on tumor growth and chromosomal instability-evidence
of E2F-1 transcriptional control over hCdt1.  Am J Pathol 2004,
165:1351-1365.
79. Xouri G, Lygerou Z, Nishitani H, Pachnis V, Nurse P, Taraviras S:
Cdt1 and geminin are down-regulated upon cell cycle exit
and are over-expressed in cancer-derived cell lines.  Eur J Bio-
chem 2004, 271:3368-3378.